Inventor
BROWN CHRISTOPHER JOHN
GB37 patents
⚠️ This page may combine multiple inventors who share the name “BROWN CHRISTOPHER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHDI FOUNDATION INC
13 patentsUS11071793B2Jul 27, 2021
Probes for imaging huntingtin protein
CHDI FOUNDATION INC5 citations83
US11059836B2Jul 13, 2021
Probes for imaging huntingtin protein
CHDI FOUNDATION INC8 citations82
US10479802B2Nov 19, 2019
Probes for imaging huntingtin protein
CHDI FOUNDATION INC8 citations82
US10137211B2Nov 27, 2018
Probes for imaging Huntingtin protein
CHDI FOUNDATION INC6 citations82
US12258355B2Mar 25, 2025
Probes for imaging huntingtin protein
CHDI FOUNDATION INC1 citations72
US11104691B2Aug 31, 2021
Probes for imaging huntingtin protein
CHDI FOUNDATION INC2 citations72
US11992535B2May 28, 2024
Compounds and probes for imaging huntingtin protein
CHDI FOUNDATION INC2 citations71
US11344637B2May 31, 2022
Probes for imaging huntingtin protein
CHDI FOUNDATION INC3 citations71
US10765764B2Sep 8, 2020
Probes for imaging huntingtin protein
CHDI FOUNDATION INC4 citations71
US10907197B2Feb 2, 2021
Probes for imaging huntingtin protein
CHDI FOUNDATION INC4 citations68
US12036291B2Jul 16, 2024
Probes for imaging huntingtin protein
CHDI FOUNDATION INC1 citations61
US11851446B2Dec 26, 2023
Probes for imaging Huntingtin protein
CHDI FOUNDATION INC0 citations61
US9649310B2May 16, 2017
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CHDI FOUNDATION INC1 citations51
RESPIVERT LTD
5 patentsUS9340545B2May 17, 2016
Quinazolin-4 (3H)—one derivatives used as P13 kinase inhibitors
RESPIVERT LTD1 citations62
US9321773B2Apr 26, 2016
Compounds
RESPIVERT LTD2 citations62
US10028959B2Jul 24, 2018
Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitors
RESPIVERT LTD0 citations51
US9834560B2Dec 5, 2017
Compounds
RESPIVERT LTD1 citations51
US9637494B2May 2, 2017
Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitors
RESPIVERT LTD0 citations51
BROWN CHRISTOPHER JOHN
3 patentsAGENCY SCIENCE TECH & RES
3 patentsUS11319344B2May 3, 2022
Non-membrane disruptive P53 activating stapled peptides
AGENCY SCIENCE TECH & RES3 citations65
US12338296B2Jun 24, 2025
Peptides and compounds that bind to elongation initiation factor 4E
AGENCY SCIENCE TECH & RES0 citations62
US9533023B2Jan 3, 2017
EIF4E binding peptides
AGENCY SCIENCE TECH & RES0 citations46
TECEXEC LTD
2 patentsCIENA CORP
2 patentsUS11736216B2Aug 22, 2023
Legacy time division multiplexing (TDM) service support in a packet network and on a packet network element
CIENA CORP0 citations59
US11095381B2Aug 17, 2021
Legacy time division multiplexing (TDM) service support in a packet network and on a packet network element
CIENA CORP0 citations59